Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial
- 1 March 2013
- journal article
- research article
- Published by Elsevier BV in The Lancet Respiratory Medicine
- Vol. 1 (1), 32-42
- https://doi.org/10.1016/s2213-2600(13)70007-9
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Six-month in vitro validation of a metered-dose inhaler electronic monitoring device: Implications for asthma clinical trial useJournal of Allergy and Clinical Immunology, 2012
- Subacute Lack of Asthma Control and Acute Asthma Exacerbation History as Predictors of Subsequent Acute Asthma Exacerbations: Evidence From Managed Care DataJournal of Asthma, 2010
- Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?British Journal of General Practice, 2008
- Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthmaInternational Journal of Clinical Practice, 2007
- Scientific rationale for using a single inhaler for asthma controlEuropean Respiratory Journal, 2007
- External validity of randomised controlled trials: “To whom do the results of this trial apply?”The Lancet, 2005
- The use of the self-management plan system of care in adult asthmaPrimary Care Respiratory Journal, 2004
- Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthmaEuropean Respiratory Journal, 1994
- The Use of β-Agonists and the Risk of Death and near Death from AsthmaThe New England Journal of Medicine, 1992
- The circumstances preceding death from asthma in young people in 1968 to 1969Respiratory Medicine, 1971